SCHEMBL7326235

SCHEMBL7326235

Cc1cc(C2(C(=O)OCc3ccccc3)CCNCC2)ccc1F

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6162717 0.78 OPRM1 (0.62) OPRM1
SCHEMBL7327775 0.78 OPRM1 (0.43) OPRM1
SCHEMBL26130614 0.74 DDB1 (0.52) OPRM1
SCHEMBL21873955 0.73 MEN1 (0.41)
Normeperidine SCHEMBL341796 0.73 OPRM1 (1.00) OPRM1
SCHEMBL5213485 0.73 DDB1 (0.51) OPRM1
SCHEMBL16104359 0.72 DDB1 (0.54) OPRM1
SCHEMBL27915147 0.72 OPRM1 (0.55) OPRM1
Normeperidine SCHEMBL4537496 0.72 OPRM1 (0.97) OPRM1
Normeperidine SCHEMBL8177568 0.72 OPRM1 (0.97) OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed